Lv51
1380 积分 2021-09-15 加入
First-in-human study to assess guselkumab (anti-IL-23 mAb) pharmacokinetics/safety in healthy subjects and patients with moderate-to-severe psoriasis
1小时前
已完结
Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials
1个月前
已完结
Efficacy and safety of coadministration of venetoclax and anti-fungal agents under therapeutic drug monitor in unfit acute myeloid leukemia and high-risk myelodysplastic syndrome with neutropenia: a single-center retrospective study
1个月前
已完结
American Society for Clinical Pharmacology and Therapeutics
5个月前
已完结
Narrow Therapeutic Index Drugs: FDA Experience, Views, and Operations
6个月前
已完结
Comparison of different immunoassay methods to detect human anti-drug antibody using the WHO erythropoietin antibody reference panel for analytes
6个月前
已完结
皖公网安备34019202002308
